// App-Quantinova.ai

: Alteration patterns of tobacco carcinogens in lung adenocarcinoma reveal novel KRAS-addicted candidate oncogenes

Researchers

Presenter

  • Mario Pepe

Principal Investigators

  • Francesco Pelizza

  • Anne-Sophie Lamort

  • Nikolaos I. Kanellakis

  • Georgios T. Stathopoulos

Medical Centers

  • Munich, Germany, Comprehensive Pneumology Center, Helmholtz-Zentrum München, Munich, Germany; Member of the German Center of Lung Research (DZL)

  • Strathclydee University, Chemical and processing engineering, Glascow, United Kingdom

  • Laboratory of Molecular Respiratory Carcinogenesis, Deprtment of Physiology, Faculty of Medicine, University of Patras, Patras, Greece

Locations

  • Germany

  • United Kingdom

  • Greece

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Lung Cancer

Biomarkers

  • KRAS proto-oncogene, GTPase

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved